Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 946064 | IM / LA |
PCP office received a notification that patient went to ER on 9/2/25 at 16:51 and discharged from ER in same day at 19:32 . RN contacted the patient by phone. The patient reported that he went to ER due to swelling and pain in his left arm following a vaccine received on 8/27/2025. Pt was informed at ER that the symptoms were consistent with a vaccine-related reaction. During the call, the patient reported that the swelling and pain had improved. He declined an earlier f/u with PCP and stated he will keep his scheduled appt. on 10/01/2025 .
None
HTN, DM, Hyperlipidema, Coronary artery diswase, Cataract
Unknown
Penicillin
Unknown.